Matrix metalloproteinase-2 (MMP-2) degrades basement membrane collagen and its abnormal expression is associated with glomerulonephritis and glomerulosclerosis. All-trans retinoic acid (ATRA) has been indicated as preventing age-related glomerulosclerosis. The results of our study showed that ATRA upregulated expression of MMP-2 mRNA and secretion of MMP-2 proteins, and increased enzymatic activity of MMP-2 in cultured mesangial cell. In addition, ATRA also caused a dose-dependent increase in the secretion of transforming growth factor-β (TGF-β1) peptides. Since TGF-β1 regulated the expression of MMP-2 in mesangial cell, it is possible that TGF-β1 is involved in ATRA-induced MMP-2 expression. Using antisense TGF-β1 RNA strategy, antisense TGF-β1 construct almost completely blocked secretion of active TGF-β1 peptides in the antisense-bearing transfectants. Northern blot analysis showed that the transfectants treated with 10–6M ATRA for 72 h neither increased nor decreased the levels of MMP-2 messenger ribonucleic acid (mRNA). Moreover, addition of anti-TGF-β1 antibodies to mesangial cell in the presence of 10–6M ATRA reduced ATRA-induced MMP-2 expression dose dependently. These data suggest that TGF-β1 might be involved in ATRA-induced MMP-2 expression.